Department of Justice Turns Eye Toward Settlement Over Off-Label Marketing of Conjunctivitis Drug

In a recent settlement, Merck has agreed to pay $5.9 million to settle claims it unlawfully marketed its conjunctivitis drug, AzaSite. When reimbursing for prescription medication, agencies like Medicare and Medicaid are only permitted to pay claims for drugs that are prescribed for their approved use. When a [...]

By | 2018-03-25T15:37:51+00:00 June 30th, 2015|Healthcare Fraud|